摘要
目的:分析中西医结合治疗在重症肺炎患者中的治疗效果。方法:选取2021年7月—2022年12月广西科技大学第一附属医院收治的重症肺炎患者150例作为研究对象,根据随机抽签法分为对照组和观察组,各75例。对照组遵医嘱使用西医常规治疗措施,观察组在西医常规治疗基础上给予扶正固本方治疗。比较两组患者治疗效果、血清炎性因子水平。结果:观察组治疗总有效率高于对照组,差异有统计学意义(P=0.014)。治疗后,两组肿瘤坏死因子-α、白细胞介素-6、降钙素原、C反应蛋白水平均下降,观察组低于对照组,差异有统计学意义(P<0.05)。结论:重症肺炎患者实施中西医结合治疗,能够降低机体炎性因子水平,提高治疗效果。
Objective:To analyze the therapeutic effect of integrated Chinese and Western medicine in patients with severe pneumonia.Methods:A total of one hundred and fifty patients with severe pneumonia admitted to the First Affiliated Hospital of Guangxi University of Science and Technology from July 2021 to December 2022 were selected as the study objects,and were divided into control group and observation group according to random drawing method,with seventy-five patients in each group.The control group was treated with conventional western medicine,and the observation group was treated with Fuzheng Guben prescription on the basis of conventional Western medicine.The therapeutic effect and serum inflammatory factor levels were compared between the two groups.Results:The total effective rate of the observation group was higher than that of the control group,the difference was statistically significant(P=0.014).After treatment,the levels of tumor necrosis factor-α,interleukin-6,procalcitonin and C-reactive protein in 2 groups were decreased,and the observation group was lower than the control group,the difference was statistically significant(P<0.05).Conclusion:The combination of Chinese and Western medicine can reduce the level of inflammatory factors and improve the therapeutic effect in patients with severe pneumonia.
作者
潘涛涛
Pan Tao-tao(the First Affiliated Hospital of Guangxi University of Science and Technology,Liuzhou 545002,Guangxi,China)
出处
《中外医药研究》
2023年第6期88-90,共3页
JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH
关键词
炎性因子
重症肺炎
扶正固本方
Inflammatory factors
Severe pneumonia
Fuzheng Guben prescription